Background
Methods
The cohort
Follow-up
Risk estimates
Results
Esophageal cancer
Cancer site | Esophagus | |||||
---|---|---|---|---|---|---|
All histologies* | Squamous cell carcinoma | Adenocarcinoma | ||||
Obs | SIR 95% CI | Obs | SIR 95% CI | Obs | SIR 95% CI | |
MEN | ||||||
Social class I | 61 | 0.68 0.52–0.88 | 44 | 0.70 0.51–0.94 | 9 | 0.78 0.36–1.48 |
Social class II | 180 | 0.79 0.68–0.91 | 123 | 0.77 0.64–0.91 | 25 | 0.90 0.58–1.33 |
Social class III | 541 | 1.04 0.95–1.13 | 378 | 1.03 0.93–1.14 | 66 | 1.07 0.83–1.36 |
Social class IV | 199 | 1.40 1.21–1.60 | 145 | 1.45 1.23–1.70 | 16 | 1.05 0.60–1.71 |
WOMEN | ||||||
Social class I | 19 | 0.44 0.26–0.69 | 13 | 0.37 0.20–0.64 | 2 | 1.20 0.14–4.32 |
Social class II | 117 | 0.70 0.58–0.84 | 100 | 0.74 0.61–0.90 | 2 | 0.32 0.04–1.14 |
Social class III | 344 | 1.11 0.99–1.23 | 270 | 1.08 0.95–1.21 | 14 | 1.28 0.70–2.14 |
Social class IV | 161 | 1.34 1.14–1.55 | 134 | 1.38 1.16–1.63 | 5 | 1.24 0.40–2.89 |
Stomach cancer – non-cardia
Cancer site | Stomach cancer (non-cardia) | Cardia cancer | Colon cancer | Rectum cancer | ||||
---|---|---|---|---|---|---|---|---|
Obs | SIR 95% CI | Obs | SIR 95% CI | Obs | SIR 95% CI | Obs | SIR 95% CI | |
MEN | ||||||||
Social class I | 280 | 0.67 0.59–0.75 | 54 | 0.69 0.52–0.90 | 394 | 1.37 1.24–1.51 | 256 | 0.98 0.86–1.10 |
Social class II | 957 | 0.86 0.81–0.92 | 169 | 0.84 0.72–0.98 | 823 | 1.14 1.07–1.22 | 736 | 1.10 1.03–1.19 |
Social class III | 2740 | 1.06 1.02–1.10 | 491 | 1.07 0.98–1.17 | 1513 | 0.93 0.88–0.98 | 1488 | 0.98 0.93–1.03 |
Social class IV | 884 | 1.20 1.12–1.27 | 149 | 1.19 1.01–1.39 | 332 | 0.78 0.69–0.86 | 375 | 0.92 0.83–1.02 |
WOMEN | ||||||||
Social class I | 184 | 0.82 0.71–0.94 | 9 | 0.51 0.23–0.97 | 273 | 1.13 1.00–1.27 | 192 | 1.10 0.95–1.26 |
Social class II | 804 | 0.94 0.88–1.01 | 59 | 0.88 0.67–1.14 | 1007 | 1.11 1.04–1.18 | 699 | 1.06 0.98–1.14 |
Social class III | 1620 | 1.05 1.00–1.10 | 130 | 1.06 0.89–1.25 | 1467 | 0.94 0.89–0.99 | 1138 | 0.98 0.93–1.04 |
Social class IV | 600 | 1.03 0.95–1.11 | 55 | 1.19 0.90–1.55 | 522 | 0.92 0.85–1.01 | 390 | 0.92 0.83–1.01 |
Cardia cancer
Colon cancer
Rectal cancer
Liver cancer
Cancer site | Liver cancer | Gall bladder & biliary tract cancer | Small intestine cancer | Pancreas cancer | ||||
---|---|---|---|---|---|---|---|---|
Obs | SIR 95% CI | Obs | SIR 95% CI | Obs | SIR 95% CI | Obs | SIR 95% CI | |
MEN | ||||||||
Social class I | 89 | 0.97 0.78–1.19 | 44 | 0.88 0.64–1.18 | 47 | 1.85 0.36–2.46 | 231 | 0.87 0.76–0.99 |
Social class II | 229 | 0.96 0.84–1.09 | 132 | 1.03 0.86–1.21 | 57 | 0.90 0.68–1.16 | 647 | 0.95 0.88–1.02 |
Social class III | 549 | 1.00 0.92–1.09 | 287 | 0.98 0.87–1.10 | 135 | 0.94 0.79–1.10 | 1564 | 1.00 0.95–1.05 |
Social class IV | 162 | 1.07 0.91–1.24 | 86 | 1.09 0.87–1.35 | 32 | 0.84 0.58–1.19 | 494 | 1.16 1.06–1.26 |
WOMEN | ||||||||
Social class I | 37 | 0.88 0.62–1.22 | 78 | 0.91 0.72–1.13 | 21 | 1.34 0.83–2.05 | 158 | 1.04 0.88–1.21 |
Social class II | 176 | 1.11 0.951.28 | 325 | 1.00 0.89–1.11 | 65 | 1.11 0.86–1.42 | 583 | 1.01 0.93–1.09 |
Social class III | 267 | 0.95 0.84–1.07 | 568 | 0.98 0.90–1.06 | 98 | 0.99 0.80–1.20 | 1004 | 0.97 0.91–1.03 |
Social class IV | 107 | 1.02 0.84–1.23 | 236 | 1.09 0.96–1.23 | 25 | 0.70 0.46–1.04 | 403 | 1.04 0.95–1.15 |